Impact of plasma tissue inhibitor of matrix metalloproteinase-1 on long-term survival in patients with colorectal cancer

Oncology

Volumn 72, Issue 3-4, 2008, Pages 205-208

  Yukawa, Norio ^a,c   Yoshikawa, Takaki ^b   Akaike, Makoto ^b   Sugimasa, Yukio ^b   Rino, Yasushi ^a   Masuda, Munetaka ^a   Imada, Toshio ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

^c YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Colorectal carcinoma; Matrix metalloproteinase; TIMP 1, prognostic value; Tissue inhibitor of matrix metalloproteinase 1

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; SENSITIVITY AND SPECIFICITY;

AGED; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR MARKERS, BIOLOGICAL;

EID: 38549132397     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112827     Document Type: Article

References (17)

1. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW: Colorectal cancer. Lancet 2005;365:153-165.
2. Berman JM, Cheung RJ, Weinberg DS: Surveillance after colorectal cancer resection. Lancet 2000;355:395-399.
3. Kuriki K, Tajima K: The increasing incidence of colorectal cancer and the preventive strategy in Japan. Asian Pac J Cancer Prev 2006;7:495-501.
4. Kotake K, Honjo S, Sugihara K, Kato T, Kodaira S, Takahashi T, Yasutomi M, Muto T, Koyama Y: Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan. Dis Colon Rectum 2003;46:32-43.
5. Kobayashi H, Mochizuki H, Sugihara K, Morita T, Kotake K, Teramoto T, Kameoka S, Saito Y, Takahashi K, Hase K, Oya M, Maeda K, Hirai T, Kameyama M, Shirouzu K, Muto T: Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery 2007;141:67-75.
6. Japanese Research Society for Cancer of the Colon and Rectum: General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus in Japan. Tokyo: Kanehara, 2006.
7. Denhardt TD, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM: Tissue inhibitor of metalloproteinase (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther 1993;59:329-341.
8. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 1992; 298:29-32.
9. Joo YE, Seo KS, Kim J, Kim HS, Rew JS, Park CS, Kim SJ: Role of tissue inhibitor of metalloproteinase (TIMPs) in colorectal carcinoma. J Korean Med Sci 1999;14:417-423.
10. Zeng ZS, Cohen AM, Zhang ZF, Stetler-Stevenson W, Guillem JG: Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Clin Cancer Res 1995;1:907-912.
11. Oberg A, Hoyhtya M, Tavelin B, Stenling R, Lindmark G: Limited value of preoperative serum analysis of matrix metalloproteinases (MMP-1, MMP-2) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer. Anticancer Res 2000; 20:1085-1092.
12. Yukawa N, Yoshikawa T, Akaike M, Sugimasa Y, Takemiya S, Yanoma S, Noguchi Y, Takanashi Y: Plasma concentration of tissue inhibitor of matrix metalloproteinase-1 in patients with colorectal carcinoma. Br J Surg 2001;88:1596-1601.
13. Yukawa N, Yoshikawa T, Akaike M, Sugimasa Y, Takemiya S, Yanoma S, Imada T, Noguchi Y: Plasma concentration of tissue inhibitor of matrix metalloproteinase-1 in patients with colorectal carcinoma. Anticancer Res 2004;24:2101-2105.
14. Holten-Andersen MN, Murphy G, Nielsen HJ, Pedersen AN, Christensen IJ, Høyer-Hansen G, Brunner N, Stephens RW: Quantitation of TIMP-1 in plasma of healthy donors and patients with advanced cancer. Br J Cancer 1999;80:495-503.
15. Holten-Andersen MN, Stephens RW, Nielsen HJ, Murphy G, Christensen IJ, Steler-Stevenson W, Brunner N: High preoperative plasma tissue inhibitor of metalloproteinase-1 level are associated with short survival of patients with colorectal cancer. Clin Cancer Res 2000;6:4292-4299.
16. Holten-Andersen MN, Nielsen HJ, Sørensen S, Jensen V, Brunner N, Christensen IJ: Tissue inhibitor of metalloproteinase-1 in the postoperative monitoring of colorectal cancer. Eur J Cancer 2006;42:1889-1896.
17. Sobin LH, Fleming ID: TNM classification of malignant tumors. Cancer 1997;80:1803-1804.